Showing results (221-230 of 352) with videos related to
Sort By:
Pageof 36
Archives of Internal Medicine|January 27, 2010
Primary esophageal carcinoma in the era of highly active antiretroviral therapyJustin Stebbing, Susan E Krown, Mark Bower, et al.Cellular Signalling|January 26, 2010
Kinases as targets in the treatment of solid tumorsGeorgios Giamas, Yik L Man, Heidrun Hirner, et al.European Journal of Cancer (Oxford, England : 1990)|May 26, 2009
Peritoneal disease in breast cancer: a specific entity with an extremely poor prognosisMark Tuthill, Robert Pell, Rosa Guiliani, et al.Oncogene|July 10, 2025
Salvage therapy with allogeneic invariant natural killer cells in a heavily pre-treated germ cell tumorBenjamin Garmezy, Joseph E Grossman, Jennifer Buell, et al.Blood|November 8, 2003
Antibody-targeted MHC complex-directed expansion of HIV-1- and KSHV-specific CD8+ lymphocytes: a new approach to therapeutic vaccinationJustin Stebbing, Brian Gazzard, Steve Patterson, et al.Cancer|July 11, 2008
The phosphorylated membrane estrogen receptor and cytoplasmic signaling and apoptosis proteins in human breast cancerPaul J Mintz, Nagy A Habib, Louise J Jones, et al.International Journal of Cancer|August 8, 2007
Phase II trial of irinotecan, cisplatin and mitomycin for relapsed small cell lung cancerDean A Fennell, Jeremy P C Steele, Jonathan Shamash, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|May 4, 2018
Image-guided thermosensitive liposomes for focused ultrasound drug delivery: Using NIRF-labelled lipids and topotecan to visualise the effects of hyperthermia in tumoursMiguel N Centelles, Michael Wright, Po-Wah So, et al.Cancer|December 6, 2006
Efficacy and safety of first- or second-line irinotecan, cisplatin, and mitomycin in mesotheliomaDean A Fennell, Jeremy P C Steele, Jonathan Shamash, et al.Cell Reports|July 28, 2015
LMTK3 Represses Tumor Suppressor-like Genes through Chromatin Remodeling in Breast CancerYichen Xu, Hua Zhang, Van Thuy Mai Nguyen, et al.Pageof 36